DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 141 filers reported holding DIPLOMAT PHARMACY INC in Q4 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $32,000 | -50.8% | 8,070 | -38.9% | 0.00% | – |
| Q3 2019 | $65,000 | -15.6% | 13,210 | +3.9% | 0.00% | -100.0% |
| Q2 2019 | $77,000 | +7600.0% | 12,710 | +16846.7% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 75 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -83.3% | 75 | -71.2% | 0.00% | – |
| Q4 2017 | $6,000 | +200.0% | 260 | +246.7% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 75 | +36.4% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -85.7% | 55 | -77.8% | 0.00% | – |
| Q3 2016 | $7,000 | -86.8% | 248 | -84.2% | 0.00% | -100.0% |
| Q2 2016 | $53,000 | +152.4% | 1,565 | +106.2% | 0.00% | – |
| Q1 2016 | $21,000 | +5.0% | 759 | +31.3% | 0.00% | – |
| Q4 2015 | $20,000 | +300.0% | 578 | +210.8% | 0.00% | – |
| Q3 2015 | $5,000 | -37.5% | 186 | -38.0% | 0.00% | – |
| Q4 2014 | $8,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 452,018 | $11,554,000 | 10.87% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 195,126 | $4,987,000 | 1.90% |
| Capital Investment Advisory Services, LLC | 144,182 | $3,685,000 | 1.84% |
| Investors Research Corp | 95,150 | $2,432,000 | 1.41% |
| Redwood Investments, LLC | 783,983 | $20,039,000 | 1.38% |
| Cortina Asset Management, LLC | 1,085,078 | $27,735,000 | 1.30% |
| Pier Capital, LLC | 362,328 | $9,261,000 | 1.27% |
| Matarin Capital Management, LLC | 628,786 | $16,071,770,000 | 1.16% |
| BROADVIEW ADVISORS LLC | 264,800 | $6,768,000 | 1.08% |
| DARUMA CAPITAL MANAGEMENT LLC | 592,659 | $15,148,000 | 0.98% |